Early Value Assessments are not shortcuts to reimbursement. They are tests of whether a technology deserves the NHS’s attention while uncertainty is still unresolved. In recent years, NICE has been …
This website uses cookies to improve your experience. We'll assume you're ok with this, but if you require more information click the 'Read More' linkAcceptRead More